FDA gives green light to PTSD marijuana study in veterans

By The Hill | Created at 2024-11-21 23:50:57 | Updated at 2024-11-25 07:14:48 3 days ago
Truth
The Food and Drug Administration (FDA) this week authorized a long-delayed clinical trial to test whether smoking marijuana can be used to treat post-traumatic stress disorder (PTSD) in veterans.  The trial, sponsored by the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS), has been blocked by the FDA since 2021. The agency had raised a variety…
Read Entire Article